Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Brommer, Ida
DOB:	22-APR-1944 (Age: 81)
Gender:	female
Address:	Jacob van Ruysdaelstraat 100 5143 GM Waalwijk (Netherlands)
ID:	8212-076428-5

Report
Date:	30-MAR-2024

Laboratory

Requested by
EHBO Europalaan 1 5171 Kaatsheuvel (Netherlands)

Specimen
Collected:	29-MAR-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	29 Mar 2024	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.9 H	4 - 6	%
Glucose [Mass/volume] in Blood	112.7 H	70 - 99	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.3	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.5 L	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	8.6	8.5 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	142.2	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.1	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	106.3 H	98 - 106	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.8	24 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	220.1 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	167.8 H	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	129.8	0 - 159	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	56.7	50 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	4.8	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c and fasting glucose, indicating suboptimal glycemic control. Lipid profile reveals hypercholesterolemia and hypertriglyceridemia, with some improvement in LDL and HDL over time. Renal function is stable with normal urea and low-normal creatinine; no evidence of microalbuminuria. Electrolytes are within normal limits except for mild hyperchloremia. Hematological parameters are unremarkable. Recommend optimization of diabetes and lipid management, and continued monitoring.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated HbA1c and fasting glucose, indicating suboptimal glycemic control. Lipid profile reveals hypercholesterolemia and hypertriglyceridemia, with some improvement in LDL and HDL over time. Renal function is stable with normal urea and low-normal creatinine; no evidence of microalbuminuria. Electrolytes are within normal limits except for mild hyperchloremia. Hematological parameters are unremarkable. Recommend optimization of diabetes and lipid management, and continued monitoring.